Evidence map›Paper›PMID 33730208›Full record

Observational studyRheumatology international2021

Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands.

Mirjam C Hegeman, Jolanda A Schoemaker-Delsing, Jacqueline T M Luttikholt, Harald E Vonkeman

Abstract readObservational Study
In one paragraph

Observational study in Rheumatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mirjam C HegemanDepartment Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands.ORCID https://orcid.org/0000-0003-3632-7622
Jolanda A Schoemaker-DelsingDepartment Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands.ORCID http://orcid.org/0000-0003-0002-7257
Jacqueline T M LuttikholtDepartment Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, The Netherlands.ORCID http://orcid.org/0000-0002-0655-4456
Harald E VonkemanDepartment of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands. h.e.vonkeman@utwente.nl.ORCID http://orcid.org/0000-0003-3792-7718

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) patients often report lacking information on medication side effects. The aims of this study were to observe how rheumatology healthcare providers deliver medication information and to determine in which specific domains information is missing. First, 12 single-blinded structured observations were performed during regular RA patient consultations. The observers noted whether and how medication and medication side effects were discussed. Second, 100 RA patients were asked to fill out an adaptation of the Satisfaction with Information about Medicines Scale (SIMS). Medication was discussed during all observed consultations. With new medication, its purpose and mode of action were explained in all cases, but possible side effects in only 33%. Overall, medication side effects were discussed in 58% of consultations. Most information delivery was verbal (92%). Response rate to the questionnaire was 61%. Overall satisfaction with medication education was mean 7.3 (± 1.9) (NRS 0-10) with a comparable high SIMS total satisfaction sum score of mean 12.3 (± 4.4). At subscale score levels, 89% were satisfied with the amount of information on the action and usage of medication, but only 47% with the information on the potential problems of medication. RA patients express overall high satisfaction with their medication education but there is still an unmet need for information on potential risks and side effects. Using the SIMS questionnaire in daily clinical practice may help focus medication education to the needs of the individual patient.

Indexed as

Patient SatisfactionAgedAntirheumatic AgentsArthritis, RheumatoidCross-Sectional StudiesFemaleHumansMaleMiddle AgedNetherlandsPatient Education as TopicPractice Patterns, Physicians'RheumatologySingle-Blind MethodAntirheumatic AgentsMedication educationMedication side effectsPatient perspectivesRheumatoid arthritisShared decision-making

Identifiers

PMID33730208
PMCPMC8019410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.